美股异动 | 诺和诺德(NVO.US)涨近6% 因竞争对手礼来(LLY.US)口服减肥药效果不及预期

智通财经
Aug 07

智通财经APP获悉,周四,诺和诺德(NVO.US)股价走高,截至发稿,该股涨近6%,报47.99美元。消息面上,该公司竞争对手礼来(LLY.US)的首个小分子口服GLP - 1药物Orforglipron实现平均减重11.2%,低于预期的13%至15%或更多。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10